Literature DB >> 11874811

Dilution of respiratory solutes in exhaled condensates.

Richard M Effros1, Kelly W Hoagland, Mark Bosbous, Daniel Castillo, Bradley Foss, Marshall Dunning, Meir Gare, Wen Lin, Feng Sun.   

Abstract

Most exhaled water is produced as gaseous water vapor, which can be collected in cooled condensers. The presence of nonvolatile solutes in these condensates suggests that droplets of respiratory fluid (RF) have also been collected. However, calculation of RF solute concentrations from condensates requires estimation of the dilution of RF droplets by water vapor. We used condensate electrolyte concentrations to calculate the dilution of RF droplets in condensates from 20 normal subjects. The total ionic concentration (conductivity) was 497 plus minus 68 (mean plus minus SEM) muM. Of this, 229 plus minus 43 muM was NH(4)(+), but little NH(4)(+) was collected from subjects with tracheostomies, indicating oral formation. The Na+ concentration in condensate ([Na+](cond)) averaged 242 plus minus 43 muM. Large variations in [Na(+)](cond) correlated well with variations of K+ in condensate ([K+](cond)) and Cl-) in condensate ([Cl-](cond)), and were attributed to differences in respiratory droplet dilution. Dividing condensate values of ([Na+] + [K+] ) by those of plasma indicated that RF represented between 0.01% and 2.00% of condensate volumes. Calculated values for Na+, K+, Cl-, lactate, and protein in RF were [Na+](RF) = 91 +/- 8 mM, [K+](RF) = 60 +/- 11 mM, [Cl-](RF) = 102 +/- 17 mM, [lactate](RF) = 44 +/- 17 mM, and [protein](RF) = 7.63 +/- 1.82 g/dl, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874811     DOI: 10.1164/ajrccm.165.5.2101018

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  79 in total

1.  Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations.

Authors:  J B McCafferty; T A Bradshaw; S Tate; A P Greening; J A Innes
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

2.  Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.

Authors:  J C Ojoo; S A Mulrennan; J A Kastelik; A H Morice; A E Redington
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

3.  Sampling airway surface liquid: non-volatiles in the exhaled breath condensate.

Authors:  Terry M Dwyer
Journal:  Lung       Date:  2004       Impact factor: 2.584

Review 4.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

5.  Exhaled breath condensate pH assays are not influenced by oral ammonia.

Authors:  K Wells; J Vaughan; T N Pajewski; S Hom; L Ngamtrakulpanit; A Smith; A Nguyen; R Turner; J Hunt
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

6.  Exposure of healthy subjects with emissions from a gas metal arc welding process: part 3--biological effect markers and lung function.

Authors:  P Brand; K Bischof; L Siry; J Bertram; T Schettgen; U Reisgen; T Kraus; M Gube
Journal:  Int Arch Occup Environ Health       Date:  2012-02-05       Impact factor: 3.015

Review 7.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

8.  Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation.

Authors:  H Marteus; D C Törnberg; E Weitzberg; U Schedin; K Alving
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

9.  Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation.

Authors:  M Corradi; P Pignatti; P Manini; R Andreoli; M Goldoni; M Poppa; G Moscato; B Balbi; A Mutti
Journal:  Eur Respir J       Date:  2004-12       Impact factor: 16.671

10.  Exhaled leukotrienes and prostaglandins in COPD.

Authors:  P Montuschi; S A Kharitonov; G Ciabattoni; P J Barnes
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.